HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center.

AbstractBACKGROUND:
Arrhythmogenic cardiomyopathy (AC) is an inheritable progressive heart disease with high risk of life-threatening ventricular arrhythmia (VA). We aimed to explore the prevalence of VA as presenting event in patients with AC over two decades, symptoms preceding VA and compare the clinical presentations and rate of AC-diagnosis over time.
METHODS:
We included consecutive AC-patients from our tertiary referral center. We recorded clinical history, VA (aborted cardiac arrest, sustained ventricular tachycardia or appropriate implantable cardioverter-defibrillator therapy), cardiac symptoms preceding VA in AC, and compared the history of patients diagnosed before and after implementation of genetic testing.
RESULTS:
We included 179 consecutive AC-patients and mutation-positive family members (95 [53%] probands, 84 [45%] female, 49 ± 17 years), 33 (18%) diagnosed before and 146 (82%) after genetic testing became available. VA led to the AC-diagnosis in 46 (26%), and was less prevalent after implementation of genetic testing (17[52%] vs. 29[20%], p < 0.001), also when adjusted for proband status (Adjusted OR 2.7, 95% CI 1.1-6.7, p = 0.03). Yearly rate of AC-diagnosis increased after implementation of genetic testing in probands (2.7 ± 1.3 vs. 6.8 ± 4.3, p = 0.01) and family members (0.7 ± 1.1 vs. 7.7 ± 5.9, p = 0.002). Most patients with VA (92%) reported cardiac symptoms prior to event, and exercise-induced syncope was the strongest marker of subsequent VA (Adjusted OR 5.3, 95% CI 1.7-16.4, p = 0.004).
CONCLUSION:
VA led to AC-diagnosis in 46% of probands and was preceded by cardiac symptoms in the majority of cases. Yearly rate of AC-diagnoses increased after the implementation of genetic testing and life-threatening presentation of AC-disease seemed to decrease.
AuthorsChristine Rootwelt-Norberg, Øyvind H Lie, Lars A Dejgaard, Monica Chivulescu, Ida S Leren, Thor Edvardsen, Kristina H Haugaa
JournalInternational journal of cardiology (Int J Cardiol) Vol. 279 Pg. 79-83 (Mar 15 2019) ISSN: 1874-1754 [Electronic] Netherlands
PMID30638987 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.
Topics
  • Adult
  • Aged
  • Arrhythmogenic Right Ventricular Dysplasia (diagnosis, genetics, physiopathology)
  • Cohort Studies
  • Cross-Sectional Studies
  • Female
  • Genetic Testing (methods, trends)
  • Genomics (methods, trends)
  • Humans
  • Male
  • Middle Aged
  • Mutation (genetics)
  • Retrospective Studies
  • Tertiary Care Centers (trends)
  • Time Factors
  • Ventricular Fibrillation (diagnosis, genetics, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: